On the Board | GenomeWeb

On the Board

Some 40 percent of the largest pharmaceutical companies have at least one board member on their board of directors who is also in a leadership position at an academic medical center, researchers led by Walid Gellad from the VA Pittsburgh Healthcare System and his colleagues report in the Journal of the American Medical Association this week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Some Ties Questioned

Financial Connections

Disappearing Postdocs

Still a Gap

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.